文献速递神经介入CTDSA

液体栓塞剂分布特征及其对脑膜中动脉栓塞后慢性硬膜下血肿结局的影响

Characterizing Liquid Embolic Distribution and Its Impact on Chronic Subdural Hematoma Outcomes following Middle Meningeal Artery Embolization.
PubMed 文献 · AJNR Am J Neuroradiol · 2025-09-02

回顾性分析88例患者109个慢性硬膜下血肿,脑膜中动脉栓塞后NCCT上液体栓塞剂多位于血肿外表面(78.0%),n-BCA较Onyx-18更易穿透硬膜(55.1% vs 17.0%)和深部腔隙(40.8% vs 7.5%)。血管造影显示硬膜穿透与更大、更快的血肿吸收及更高完全吸收几率相关,但NCCT上深部腔隙穿透在多因素调整后并非独立预测因素。

要点

  • 脑膜中动脉栓塞后NCCT上液体栓塞剂最常见于血肿外表面(78.0%),其次为血肿内(14.7%)和内表面(7.3%)。
  • 血管造影显示硬膜穿透者血肿绝对缩小1.05 cm vs 0.66 cm,完全吸收几率近4倍。
  • n-BCA较Onyx-18更易穿透硬膜和深部腔隙,但NCCT深部穿透非独立预测因素。

核心结论

  • 血管造影显示硬膜穿透与更大、更快的慢性硬膜下血肿吸收及更高完全吸收几率相关;n-BCA与更深腔隙穿透相关,但NCCT上深部腔隙穿透在多因素调整后非独立预测因素。

研究设计与样本

  • 单中心回顾性研究,纳入2019-2024年慢性硬膜下血肿>5 mm患者88例(109个单侧血肿),排除随访影像<1个月或使用弹簧圈/颗粒栓塞者。

关键影像表现/征象

  • 随访NCCT上液体栓塞剂位于血肿外表面85例(78.0%)、血肿内16例(14.7%)、血肿内表面8例(7.3%)。
  • n-BCA穿透硬膜55.1%、到达深部腔隙40.8%,Onyx-18分别为17.0%和7.5%(均P < .0001)。

诊断标准与关键数值

  • 硬膜穿透者平均绝对缩小1.05 cm vs 无穿透者0.66 cm(P < .001),平均缩小百分比73.8% vs 53.5%(P = .01),平均吸收速率0.013 mm/d vs 0.007 mm/d(P = .001)。
  • NCCT深部腔隙穿透者吸收速率0.014 mm/d vs 0.008 mm/d(P = .01),但未影响绝对缩小、缩小百分比或完全吸收。
  • 回归分析:硬膜穿透与更快吸收相关(β = 0.004 mm/d,P = .04)、更大缩小百分比(β = 32.65%,P = .001)、完全吸收几率近4倍(β = 1.38,P = .04)。

临床应用与阅片要点

  • 可用血肿外表面、血肿内、血肿内表面三分法在NCCT上描述液体栓塞剂分布。
  • 血管造影显示硬膜穿透可能提示更好的血肿吸收和完全吸收几率,但NCCT深部腔隙穿透在多因素调整后非独立预测因素。

局限性

  • 单中心回顾性研究。
  • 样本量较小(88例患者、109个血肿)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: The NCCT appearance of liquid embolic material post middle meningeal artery embolization (MMAE) for chronic subdural hematomas (cSDHs) is poorly described. We aimed to categorize the spectrum of postprocedural liquid embolic distribution and determine whether embolic penetration impacts resorption.

MATERIALS AND METHODS: We retrospectively reviewed patients with cSDH >5 mm at a single institution from 2019-2024. Patients with <1 month of follow-up imaging or embolization with coils or particles were excluded. Embolic membrane penetration during angiography was recorded, and the postprocedural appearance of embolic material was classified. Regression analyses were performed to assess if specific embolic distributions were associated with greater resorption.

RESULTS: Eighty-eight patients (73.9% men; mean age 73.5 ± 11.2 years) with 109 unilateral cSDHs were included. Membrane penetration occurred in 39 cases (35.8%). On follow-up NCCT, liquid embolic material was visualized on the outer surface of the cSDH in 85 cases (78.0%), within the cSDH in 16 cases (14.7%), and on the inner surface of the cSDH in 8 cases (7.3%). n-BCA was more likely to penetrate the subdural membrane (55.1%) and reach deeper compartments (40.8%) compared with Onyx-18 (17.0% and 7.5%; both P < .0001). Membrane penetration was associated with greater mean absolute reduction (1.05 cm versus 0.66 cm, P < .001), mean percent reduction (73.8% versus 53.5%, P = .01), and a faster average resorption rate (0.013 mm/d versus 0.007 mm/d, P = .001). Deeper compartment penetration visualized on follow-up NCCT was associated with faster resorption on univariate analysis (0.014 mm/d versus 0.008 mm/d, P = .01) but did not impact absolute reduction, percent reduction, or complete resorption. In regression analysis, membrane penetration was associated with faster resorption (β = 0.004 mm/d, P = .04), greater percent reduction (β = 32.65%, P = .001), and nearly 4 times the odds of complete resolution (β = 1.38, P = .04).

CONCLUSIONS: We present a framework for characterizing the appearance of liquid embolic agents after MMAE. Visualized membrane penetration during angiography was associated with greater and faster cSDH resorption and higher odds of complete resolution. n-BCA was associated with deeper compartment penetration; however, deeper compartment penetration on NCCT was not independently predictive of improved outcomes after adjustment for covariates.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Ganga A, Shaaya E, Santos-Fontanez S, et al. Characterizing Liquid Embolic Distribution and Its Impact on Chronic Subdural Hematoma Outcomes following Middle Meningeal Artery Embolization. AJNR Am J Neuroradiol. 2025. PMID: 40204351. doi:10.3174/ajnr.A8779

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。